Bookmark and Share

BIOLASE (BLTI) Announces Appointment of Dmitri Boutoussov to Chief Technology Officer

IRVINE, CA — (Marketwire) — 10/04/10 — BIOLASE Technology, Inc. (NASDAQ: BLTI), the world’s leading dental laser company, announced today that Vice President of Engineering Dmitri Boutoussov, Ph.D., has been promoted to Chief Technology Officer, effective immediately. In the newly created position, Boutoussov will report directly to Federico Pignatelli, Chairman and CEO.

Boutoussov, 47, has more than 18 years in developing laser technologies for dentistry and medical applications in the U.S. and Europe. He has authored and co-authored more than 20 U.S. and international patents and patent applications, and more than 25 publications in peer reviewed magazines and conferences. He also has lectured in the U.S. and internationally on Laser Physics and Laser Medical Applications.

He joined BIOLASE in 2000 as Director of Engineering and was appointed Vice President of Engineering in 2004. In this position, Boutoussov was responsible for the development of all current and new BIOLASE products, was a key participant in expanding the Company’s intellectual property portfolio, directed the education and training of sales and service personnel and established strategic partnerships with international suppliers.

Pignatelli said, “Dmitri has been integral to the development of our product offerings and will continue to play a key role in the future success of constant innovation at BIOLASE. Dmitri has played a critical role in our product and technology success, serving for over 10 years at the Company with great dedication and high competence. His knowledge and expertise in laser technology is profound and his contributions will be important to not only the introduction of new products, but also to the development of our technology roadmap and the direction the Company will take in medical applications other than dentistry.”

Prior to his tenure at BIOLASE, Boutoussov among others was also a technical manager with Laser Medical Systems, GmbH, in Vienna, Austria, and a research engineer with Ioffe Institute, Academy of Sciences, in St. Petersburg, one of the most recognized science schools worldwide.

Boutoussov holds both a Ph.D. and a Master of Science degree in Physics from the Polytechnic University in St. Petersburg.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the world’s leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company’s products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company’s actual results to differ materially from the statements contained herein, and are described in the Company’s reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

For further information, please contact:
Jill Bertotti (investors)
Len Hall (media)
Allen & Caron

Monday, October 4th, 2010 Uncategorized